FDA clears DEXTER for ventral hernia repair
The U.S. Food and Drug Administration granted 510(k) clearance for use of Distalmotion's DEXTER robotic surgery system in ventral hernia repair.
Verified eventDistalmotionAug 13, 2026
Evidence notes
- The clearance expands DEXTER's U.S. label to the four highest-volume soft-tissue ambulatory procedure categories.
- Distalmotion reports that surgeons have used DEXTER in more than 4,000 patients.
- The system is designed for surgeon-controlled robotic assistance within established operating-room workflows.